The Europe Meningococcal Vaccine Market would witness market growth of 8% CAGR during the forecast period (2020-2026). Meningococcal vaccines are perceiving a significant demand in line with a prominent increase in routine immunization. Increasing use of meningococcal vaccines for immunizing special risk groups, such as travellers, or military personnel is fueling gains in the market.
Moreover, non-profit organizations offering funds for research projects, healthcare professionals training, and providing information & support to patients. All these factors are anticipated to propel market growth. For example, the Meningitis Research Foundation has approved 161 research grants and invested about USD 28.0 million for scientific researches. Through this organization, people and expertise come together in order to face challenges in preventing meningitis.
In addition to it, the phase III vaccines in trials that are expected to be commercialized over the projected period, are anticipated to drive the market growth. For example, MenACYW, which is a conjugate vaccine manufactured by Sanofi, is in phase III clinical trial.
There is an increasing prevalence of various types of bacteria that cause meningococcal meningitis. The most common type of meningitis causing bacteria are A, B, C, W, Y, and type X that was more lately reported in Africa, continue to underline the criticality of more effective vaccine of meningococcal to be available in the coming years.
Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Meningococcal Vaccine Market in Europe is expected to register a CAGR of 8% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By Brand
- Bexsero
- Trumenba
- Nimenrix
- Menactra
- Menveo
- Other Brands
By Type
- Bivalent
- Quadrivalent
- Other Types
By Age Group
- Infants (0 to 2 years)
- Children (2 years & above)
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Sanofi S.A.
- Walvax Biotechnology Co., Ltd.
- Bio-Manguinhos (Oswaldo Cruz Foundation)
- Bio-Med Pvt. Ltd.
- Chongqing Zhifei Biological Products Co., Ltd.
- Hualan Biological Engineering, Inc.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Meningococcal Vaccine Market, by Brand
1.4.2 Europe Meningococcal Vaccine Market, by Type
1.4.3 Europe Meningococcal Vaccine Market, by Age Group
1.4.4 Europe Meningococcal Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. Europe Meningococcal Vaccine Market by Brand
4.1 Europe Bexsero Market by Country
4.2 Europe Trumenba Market by Country
4.3 Europe Nimenrix Market by Country
4.4 Europe Menactra Market by Country
4.5 Europe Menveo Market by Country
4.6 Europe Other Brands Market by Country
Chapter 5. Europe Meningococcal Vaccine Market by Type
5.1 Europe Bivalent Market by Country
5.2 Europe Quadrivalent Market by Country
5.3 Europe Other Types Market by Country
Chapter 6. Europe Meningococcal Vaccine Market by Age Group
6.1 Europe Children (2 years & above) and Adults Market by Country
6.2 Europe Infants(0 to 2 years) Market by Country
Chapter 7. Europe Meningococcal Vaccine Market by Country
7.1 Germany Meningococcal Vaccine Market
7.1.1 Germany Meningococcal Vaccine Market by Brand
7.1.2 Germany Meningococcal Vaccine Market by Type
7.1.3 Germany Meningococcal Vaccine Market by Age Group
7.2 UK Meningococcal Vaccine Market
7.2.1 UK Meningococcal Vaccine Market by Brand
7.2.2 UK Meningococcal Vaccine Market by Type
7.2.3 UK Meningococcal Vaccine Market by Age Group
7.3 France Meningococcal Vaccine Market
7.3.1 France Meningococcal Vaccine Market by Brand
7.3.2 France Meningococcal Vaccine Market by Type
7.3.3 France Meningococcal Vaccine Market by Age Group
7.4 Russia Meningococcal Vaccine Market
7.4.1 Russia Meningococcal Vaccine Market by Brand
7.4.2 Russia Meningococcal Vaccine Market by Type
7.4.3 Russia Meningococcal Vaccine Market by Age Group
7.5 Spain Meningococcal Vaccine Market
7.5.1 Spain Meningococcal Vaccine Market by Brand
7.5.2 Spain Meningococcal Vaccine Market by Type
7.5.3 Spain Meningococcal Vaccine Market by Age Group
7.6 Italy Meningococcal Vaccine Market
7.6.1 Italy Meningococcal Vaccine Market by Brand
7.6.2 Italy Meningococcal Vaccine Market by Type
7.6.3 Italy Meningococcal Vaccine Market by Age Group
7.7 Rest of Europe Meningococcal Vaccine Market
7.7.1 Rest of Europe Meningococcal Vaccine Market by Brand
7.7.2 Rest of Europe Meningococcal Vaccine Market by Type
7.7.3 Rest of Europe Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 2 Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 Europe Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 6 Europe Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 7 Europe Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 8 Europe Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 9 Europe Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Menactra Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Menactra Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe Menveo Market by Country, 2016 - 2019, USD Million
TABLE 14 Europe Menveo Market by Country, 2020 - 2026, USD Million
TABLE 15 Europe Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 16 Europe Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 17 Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 Europe Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 20 Europe Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 21 Europe Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 22 Europe Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 23 Europe Other Types Market by Country, 2016 - 2019, USD Million
TABLE 24 Europe Other Types Market by Country, 2020 - 2026, USD Million
TABLE 25 Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 Europe Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 28 Europe Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 29 Europe Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 30 Europe Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 31 Europe Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 32 Europe Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 33 Germany Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 Germany Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 Germany Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 Germany Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 Germany Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 38 Germany Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 39 Germany Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 40 Germany Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 41 UK Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 42 UK Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 43 UK Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 44 UK Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 45 UK Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 46 UK Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 47 UK Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 48 UK Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 49 France Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 50 France Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 51 France Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 52 France Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 53 France Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 54 France Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 55 France Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 56 France Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 57 Russia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 58 Russia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 59 Russia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 60 Russia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 61 Russia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 62 Russia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 63 Russia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 64 Russia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 65 Spain Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 66 Spain Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 67 Spain Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 68 Spain Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 69 Spain Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 70 Spain Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 71 Spain Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 72 Spain Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 73 Italy Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 74 Italy Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 75 Italy Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 76 Italy Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 77 Italy Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 78 Italy Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 79 Italy Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 80 Italy Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 81 Rest of Europe Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 82 Rest of Europe Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 83 Rest of Europe Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 84 Rest of Europe Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 85 Rest of Europe Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 86 Rest of Europe Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 87 Rest of Europe Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 88 Rest of Europe Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 89 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key Information – Sanofi S.A.
TABLE 92 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 93 Key Information – Bio-Manguinhos
TABLE 94 key information – Bio-Med Pvt. Ltd.
TABLE 95 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 96 Key Information – Hualan Biological Engineering, Inc.
TABLE 97 key information – Incepta Pharmaceuticals Ltd.
TABLE 98 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research